Keywords: UCB, Vimpat, Epilepsy, EMA, Europe

UCB’s Vimpat syrup recalled in EU due to batch defect

Article | 25 July 2011

Print This

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has agreed to a recall of Vimpat 15mg/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in